HIGHLIGHTS
- who: Mellitus et al. from the University of Aberdeen, United Kingdom have published the paper: Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus, in the Journal: (JOURNAL) of 10/Oct/2020
- what: The aim of this study was to investigate the role of serum levels of irisin in predicting clinical outcome in HF patients with T2DM. The results of the study were completely consistent with the previous hypothesis, while direct comparison of discriminatory potencies of both biomarkers provided evidence for their comparability.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.